Product Linked to Development of Non-Hodgkin’s Lymphoma, Other Types of Cancer
LOS ANGELES (Jan. 20, 2016) – The national law firm of Baron & Budd is investigating potential legal action against Monsanto Co., the maker of the weed killer RoundUp. The product has been linked to an increased risk of several forms of cancer in farm workers and others who have been exposed to the herbicide. These include follicular lymphoma, b-cell lymphoma, non-Hodgkin’s lymphoma and several others.
According to a recent Reuters news article, many people across the country are considering taking legal action against Monsanto, claiming that RoundUp has led to the development of cancer in either themselves or their loved ones. They claim that Monsanto has long been aware of the fact that glyphosate, the main ingredient in the weed killer, posed a risk to human health. In March, the World Health Organization declared that enough evidence existed to classify glyphosate as a probable carcinogen.
Reuters reported that RoundUp generated nearly $5 billion in revenue for Monsanto during its 2015 fiscal year. The company, according to the article, denies that glyphosate is a carcinogen and states it is one of the safest pesticides available. However, farm workers throughout the nation are claiming otherwise, saying that they have become ill after being exposed to the herbicide.
“We believe there is a great deal of evidence that suggests Monsanto was clearly aware of the hazards presented by glyphosate,” said environmental attorney Thomas Sims of Baron & Budd. “Whenever a corporation introduces a harmful product to the public, it must be held responsible for any illnesses that product causes.”
ABOUT BARON & BUDD, P.C.
The law firm of Baron & Budd, P.C., with offices in Dallas, Baton Rouge, New Orleans, Austin and Los Angeles, is a nationally recognized law firm with a nearly 40-year history of "Protecting What’s Right" for people, communities and businesses harmed by negligence. Baron & Budd’s size and resources enable the firm to take on large and complex cases. The firm represents individuals and government and business entities in areas as diverse as dangerous pharmaceuticals and medical devices, environmental contamination, the Gulf oil spill, financial fraud, overtime violations, deceptive advertising, automotive defects, trucking accidents, nursing home abuse, and asbestos-related illnesses such as mesothelioma.